Adherium Ltd Asset Resilience Ratio
Adherium Ltd asset resilience ratio. Adherium Ltd (ADR) has an Asset Resilience Ratio of 15.45% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Adherium Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Adherium Ltd (2017–2023)
Asset resilience ratio of Adherium Ltd from 2017 to 2023. This chart shows how Adherium Ltd's Asset Resilience Ratio has changed over time. Read debt load of Adherium Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Adherium Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ADR current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$642.28K | 15.45% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$642.28K | 15.45% |
Asset Resilience Insights
- Good Liquidity Position: Adherium Ltd maintains a healthy 15.45% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Adherium Ltd Industry Peers by Asset Resilience Ratio
Compare Adherium Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
Adherium Ltd Asset Resilience Ratio by Year (2017–2023)
Adherium Ltd asset resilience ratio by year from 2017 to 2023. The table below shows the annual Asset Resilience Ratio data for Adherium Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 71.58% | AU$9.08 Million ≈ $6.42 Million |
AU$12.68 Million ≈ $8.97 Million |
+9.67pp |
| 2022-06-30 | 61.91% | AU$5.28 Million ≈ $3.74 Million |
AU$8.53 Million ≈ $6.04 Million |
-26.21pp |
| 2021-06-30 | 88.13% | AU$15.02 Million ≈ $10.62 Million |
AU$17.04 Million ≈ $12.06 Million |
+19.89pp |
| 2020-06-30 | 68.23% | AU$4.58 Million ≈ $3.24 Million |
AU$6.72 Million ≈ $4.75 Million |
+34.23pp |
| 2019-06-30 | 34.00% | AU$763.00K ≈ $539.87K |
AU$2.24 Million ≈ $1.59 Million |
-47.88pp |
| 2018-06-30 | 81.88% | AU$12.54 Million ≈ $8.88 Million |
AU$15.32 Million ≈ $10.84 Million |
-8.90pp |
| 2017-06-30 | 90.79% | AU$22.78 Million ≈ $16.12 Million |
AU$25.09 Million ≈ $17.75 Million |
-- |
About Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more